Inventor
GOLZ STEFAN
DE18 patents
⚠️ This page may combine multiple inventors who share the name “GOLZ STEFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GOLZ STEFAN
4 patentsUS9943522B2Apr 17, 2018
Use of cathepsin K inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure
GOLZ STEFAN5 citations69
US8088584B2Jan 3, 2012
LTBP2 as a biomarker and diagnostic target
GOLZ STEFAN3 citations53
US8252525B2Aug 28, 2012
Diagnostics and therapeutics for diseases associated with G-protein coupled receptor AdipoR1(AdipoR1)
GOLZ STEFAN0 citations48
US8236540B2Aug 7, 2012
Isolated luciferases and the use thereof
GOLZ STEFAN0 citations46
Bayer Pharma AG
4 patentsUS8343745B2Jan 1, 2013
Acylglycerol acyltransferase-like protein MGAT-X1 and uses thereof
Bayer Pharma AG0 citations50
US9745557B2Aug 29, 2017
Isolated luciferases and the use thereof
Bayer Pharma AG0 citations48
US10130633B2Nov 20, 2018
Compounds
Bayer Pharma AG0 citations39
US9884063B2Feb 6, 2018
Amido-substituted azole compounds
Bayer Pharma AG0 citations38
BAYER HEALTHCARE AG
3 patentsUS7338781B2Mar 4, 2008
Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof
BAYER HEALTHCARE AG5 citations60
US7491550B2Feb 17, 2009
Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2)
BAYER HEALTHCARE AG0 citations50
US7465548B2Dec 16, 2008
Methods of screening for potential therapeutics for diseases associated with G-protein coupled receptor HM74a
BAYER HEALTHCARE AG0 citations47